URUGUAY / PARAGUAY |
|
Authority |
ministerio de salud publica y Bienestar social |
website |
www.mspbs.gov.py/ http://www.msp.gub.uy/index_1.html |
if any |
|
DOSSIER REQUIRMENTS |
S.No.: |
Documents |
Page No.: |
|||
1. |
Free sale certificate legalized ………………………………………. |
|
|||
2. |
GMP certificate …………………………………………………….. |
|
|||
6. |
Protocol …………………………………………………………….. |
|
|||
|
6.1 |
Proposed name ……………………………………………... |
|
||
|
6.2 |
Design ……………………………………………………… |
|
||
|
Primary packing ……………………………………………. |
|
|||
|
Secondary packing ………………………………….……... |
|
|||
|
Insert ……………………………………………….……….. |
|
|||
|
6.3 |
Formula quail-quantitative………………………………..… |
|
||
|
6.4 |
Monograph ………………………………………………… |
|
||
|
|
6.4.1 |
Active Raw Material (Therapeutic Group, ATC Classification, INN,BAN,SDS), Certificate of analysis supplier and own. …………. |
|
|
|
|
6.4.2 |
Excipients …………………………………………. |
|
|
|
6.5 |
Packing material specification …………………………….. |
|
||
|
6.6 |
Manufacturing process …………………………………….. |
|
||
|
|
6.6.1 |
Detailed description of the process ……………….. |
|
|
|
|
6.6.2 |
Formula per batch . ……………………………….. |
|
|
|
|
6.6.3 |
Batch record ………………………………………. |
|
|
|
|
6.6.4 |
In process control …….…………………………… |
|
|
|
6.7 |
Analytical methodology of finished product ……………… |
|
||
|
|
6.7.1 |
Specifications …………………………………….. |
|
|
|
|
6.7.4 |
Certificate of analysis with spectra, chromatograms etc ………………………………... |
|
|
|
|
6.7.5 |
Methodology validation incase no pharmacopoeia method used ……………………………………… |
|
|
|
|
6.7.6 |
Microbiological controls ………………………….. |
|
|
|
6.8 |
Stability studies …………………………………………….. |
|
||
|
|
6.8.1 |
Long term …………………………………………. |
|
|
|
|
6.8.2 |
Accelerated…………………………….………….. |
|
|
|
|
6.8.3 |
Duration and schedule ………………..…………… |
|
|
|
|
6.8.4 |
Experimental conditions ………………..…………. |
|
|
|
|
6.8.5 |
Batch size and number………………..…………… |
|
|
|
|
6.8.6 |
Type of packing………………..………………….. |
|
|
|
|
6.8.7 |
Shelf life propose………………..………………… |
|
|
|
|
6.8.8 |
Test used during the study………………..……….. |
|
|
|
|
6.8.10 |
Degradation product study………………..……….. |
|
|
|
|
6.8.11 |
Table, number and quantity of batches …………… |
|
|
|
6.9 |
Pharmacology, toxicological studies ………………..….….. |
|
||
|
6.1 |
Clinical studies ………………..………………………….... |
|
Toc for uruguay or paraguay ,toc formate for dossier